Physician

Nikila V. Kumar, M.D.

According to 2025 Medicare claims, Nikila Kumar, M.D. (NPI: 1295095495) practices rheumatology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is ARIZONA ARTHRITIS & RHEUMATOLOGY ASSOCIATES P C (NPI: 1366489254; TIN: 860765242) and primary practice location at 85210-6882.

Kumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 859 traditional Medicare patients, billed 198,985 HCPCS/CPT codes, and received $3,076,618 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,762 prescription claims across 464 beneficiaries totaling $3,502,596 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2016 DME data shows 26 claims. Open Payments data shows 243 records totaling $927,918. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $9,955 to $3,076,618. Similarly, Part D prescription costs have moved sharply higher in recent years, from $20,968 to $3,502,596. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	46	134	$9,955
2016	112	335	$26,302
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	605	65,060	$774,738
2020	965	236,794	$2,772,051
2021	806	180,640	$2,288,226
2022	1,066	253,159	$3,101,530
2023	1,049	247,579	$3,247,379
2024	859	198,985	$3,076,618

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	43	163	$20,968
2016	141	328	$62,132
2017	81	447	$281,897
2018	76	401	$232,031
2019	314	775	$728,844
2020	493	1,918	$2,103,510
2021	454	1,933	$2,882,912
2022	507	2,035	$3,432,244
2023	500	1,979	$3,584,369
2024	464	1,762	$3,502,596

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	26	$1,540
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	673	1,498	$94
80053	Blood test, comprehensive group of blood chemicals	619	1,360	$10
36415	Insertion of needle into vein for collection of blood sample	642	1,492	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	507	1,156	$8
85652	Red blood cell sedimentation rate, to detect inflammation, automated	470	1,091	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	82	2,856	$885,829
Enbrel Sureclick	Etanercept	49	1,794	$497,332
Enbrel Mini	Etanercept	55	1,708	$450,782
Xeljanz Xr	Tofacitinib Citrate	61	2,250	$441,854
Enbrel	Etanercept	23	728	$190,675

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	178	$3,594	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	65	$924,324	Amgen Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nikila V. Kumar, M.D.?

Tedicare shows public-source Medicare data for Nikila V. Kumar, M.D. (NPI 1295095495), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nikila V. Kumar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nikila V. Kumar, M.D.?

Nikila V. Kumar, M.D. is linked to ARIZONA ARTHRITIS & RHEUMATOLOGY ASSOCIATES P C (billing NPI 1366489254) in the available physician profile data.

Does Nikila V. Kumar, M.D. have Open Payments data?

Nikila V. Kumar, M.D. has 243 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.